The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
Silvia Migliaccio, Marina Brama, Giovanni SperaCattedra di Medicina Interna, Dipartimento di Fisiopatologia Medica, Università degli Studi di Roma “La Sapienza”, Italy Abstract: Osteoporosis is a skeletal metabolic disease characterized by a compromised bone fragility,...
Saved in:
Main Authors: | Silvia Migliaccio, Marina Brama, Giovanni Spera |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2007
|
Subjects: | |
Online Access: | https://doaj.org/article/54dd43997e2a4ad9bab5ca08bb97a0fb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of estrogens on skin aging and the potential role of SERMs
by: Susan Stevenson, et al.
Published: (2007) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
by: Luigi Gennari, et al.
Published: (2010) -
Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
by: Esteban Jódar-Gimeno
Published: (2007) -
Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
by: Oliver Bock, et al.
Published: (2008) -
Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
by: John Sunyecz
Published: (2008)